Initiating Coverage on Zynex Inc. (ZYXI)

Zynex Inc.’s (ZYXI) stock was seriously punished with the April 2009 restatement announcement and, despite revenue growth of almost 60% in 2009 and 30% through the first nine months of 2010, has yet to fully recover. Until there is resolution on what we would characterize as “significant” lingering concerns (most notably the outstanding lawsuit and [...]